What are the major factors driving the growth of the liquid biopsy market?

In the year 2025, the industry size of liquid biopsy is assessed at USD 7.39 billion. Read More

What would be the CAGR of liquid biopsy Market over the forecast period?

Liquid Biopsy Market size was over USD 6.69 billion in 2024 and is anticipated to cross USD 30.22 billion by 2037, growing at more than 12.3% CAGR during the forecast period i.e., between 2025-2037.. Read More

Which region will provide more business opportunities for growth of liquid biopsy market in future?

The major players in the market are Qiagen, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., Illumina, Inc., Inivata Limited, Agena Bioscience, Inc., Thermo Fisher Scientific, Guardant Health, Inc., and others. Read More

Liquid Biopsy Market Trends

Global Liquid Biopsy Market TOC

Market Definition
1. Market Definition
2. Market Segmentation
3. Product Overview
Research Methodology
1. Research Process
2. Primary Research
  1. Manufacturers
  2. End-users
3. Secondary research
4. Market size estimation
Executive Summary- Global Liquid Biopsy Market
Analysis of Market Dynamics
1. Drivers
2. Restraints
3. Opportunities
4. Trends
Regulatory & Standards Landscape
Pricing Analysis
Epidemiology Analysis
Impact of COVID-19 on the Liquid Biopsy Market
1. Pre-COVID-19 Scenario, 2017-19
2. COVID-19 scenario, 2020
3. Post-COVID-19 scenario
Comparative Analysis (Liquid biopsy vs Tissue-based biopsy)
End-User Usability Analysis
Competitive Structure
Global Liquid Biopsy Market Outlook
1. Global Liquid Biopsy Market Segmentation Analysis 2019-2028
  1. By Product, 2019-2028F (in USD Million)
    1. Tools, 2019-2028F (USD Million)
      1. Next generation sequencing (NGS), 2019-2028F (USD Million)
      2. Polymerase chain reaction (PCR), 2019-2028F (USD Million)
      3. Microarrays, 2019-2028F (USD Million)
    2. Assay kits & reagents, 2019-2028F (USD Million)
    3. Services, 2019-2028F (USD Million)
  2. By Biomarker Type, 2019-2028F (in USD Million)
    1. Circulating Tumor Cells, 2019-2028F (USD Million)
    2. Circulating Tumor DNA, 2019-2028F (USD Million)
    3. Exosomes, 2019-2028F (USD Million)
    4. Circulating RNA & Proteins, 2019-2028F (USD Million)
    5. Nucleosomes, 2019-2028F (USD Million)
  3. By Sample, 2019-2028F (in USD Million)
    1. Blood, 2019-2028F (USD Million)
    2. Urine, 2019-2028F (USD Million)
    3. Others, 2019-2028F (USD Million)
  4. By Clinical Application, 2019-2028F (in USD Million)
    1. Early Disease Screening, 2019-2028F (USD Million)
    2. Therapy Selection, 2019-2028F (USD Million)
    3. Treatment Response Monitoring, 2019-2028F (USD Million)
    4. Molecular Health Monitoring, 2019-2028F (USD Million)
    5. Others, 2019-2028F (USD Million)
  5. By Disease Indication, 2019-2028F (in USD Million)
    1. Lung Cancer, 2019-2028F (USD Million)
    2. Colorectal Cancer, 2019-2028F (USD Million)
    3. Breast Cancer, 2019-2028F (USD Million)
    4. Prostate Cancer, 2019-2028F (USD Million)
    5. Liver Cancer, 2019-2028F (USD Million)
    6. Head & Neck Cancer, 2019-2028F (USD Million)
    7. Others, 2019-2028F (USD Million)
  6. By End-User, 2019-2028F (in USD Million)
    1. Hospitals, 2019-2028F (USD Million)
    2. Clinics, 2019-2028F (USD Million)
    3. Research Laboratories, 2019-2028F (USD Million)
    4. Academic Institutes, 2019-2028F (USD Million)
    5. Others, 2019-2028F (USD Million)
  7. By Region, 2019-2028F (in USD Million)
    1. North America, 2019-2028F (in USD Million)
    2. Europe, 2019-2028F (in USD Million)
    3. Asia Pacific, 2019-2028F (in USD Million)
    4. Latin America, 2019-2028F (in USD Million)
    5. Middle East & Africa, 2019-2028F (in USD Million)
North America Liquid Biopsy Market Outlook
1. North America Liquid Biopsy Market Segmentation Analysis 2019-2028
  1. By Product, 2019-2028F (in USD Million)
  2. By Biomarker Type, 2019-2028F (in USD Million)
  3. By Sample, 2019-2028F (in USD Million)
  4. By Clinical Application, 2019-2028F (in USD Million)
  5. By Disease Indication, 2019-2028F (in USD Million)
  6. By End-User, 2019-2028F (in USD Million)
  7. By Country, 2019-2028F (in USD Million)
Latin America Liquid Biopsy Market Outlook
1. Latin America Liquid Biopsy Market Segmentation Analysis 2019-2028
  1. By Product, 2019-2028F (in USD Million)
  2. By Biomarker Type, 2019-2028F (in USD Million)
  3. By Sample, 2019-2028F (in USD Million)
  4. By Clinical Application, 2019-2028F (in USD Million)
  5. By Disease Indication, 2019-2028F (in USD Million)
  6. By End-User, 2019-2028F (in USD Million)
  7. By Country, 2019-2028F (in USD Million)
Europe Liquid Biopsy Market Outlook
1. Europe Liquid Biopsy Market Segmentation Analysis 2019-2028
  1. By Product, 2019-2028F (in USD Million)
  2. By Biomarker Type, 2019-2028F (in USD Million)
  3. By Sample, 2019-2028F (in USD Million)
  4. By Clinical Application, 2019-2028F (in USD Million)
  5. By Disease Indication, 2019-2028F (in USD Million)
  6. By End-User, 2019-2028F (in USD Million)
  7. By Country, 2019-2028F (in USD Million)
Asia Pacific Liquid Biopsy Market Outlook
1. Asia Pacific Liquid Biopsy Market Segmentation Analysis 2019-2028
  1. By Product, 2019-2028F (in USD Million)
  2. By Biomarker Type, 2019-2028F (in USD Million)
  3. By Sample, 2019-2028F (in USD Million)
  4. By Clinical Application, 2019-2028F (in USD Million)
  5. By Disease Indication, 2019-2028F (in USD Million)
  6. By End-User, 2019-2028F (in USD Million)
  7. By Country, 2019-2028F (in USD Million)
Middle East & Africa Liquid Biopsy Market Outlook
1. Middle East & Africa Liquid Biopsy Market Segmentation Analysis 2019-2028
  1. By Product, 2019-2028F (in USD Million)
  2. By Biomarker Type, 2019-2028F (in USD Million)
  3. By Sample, 2019-2028F (in USD Million)
  4. By Clinical Application, 2019-2028F (in USD Million)
  5. By Disease Indication, 2019-2028F (in USD Million)
  6. By End-User, 2019-2028F (in USD Million)
  7. By Country, 2019-2028F (in USD Million)
Competitive Structure
1. Qiagen
2. F. Hoffmann-La Roche Ltd
3. Bio-Rad Laboratories, Inc.
4. Illumina, Inc.
5. Inivata Limited
6. Agena Bioscience, Inc.
7. Thermo Fisher Scientific
8. Guardant Health, Inc.

Liquid Biopsy Market Trends

Growth Drivers

Growing Incidence of Cancer
Increasing Research and Developments in Diagnostic Technologies

Challenges

Changing Regulatory Standards Associated with Biopsy
Preference for Alternative Types of Biopsy

Liquid Biopsy Market: Key Insights

Regionally, the global market is segmented into five major regions, which include North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. Among the markets in these regions, the North American liquid biopsy market is estimated to hold the leading market share of 36.19% and attain a revenue of USD 9363.1 Million by the end of 2028. The market in the region is further expected to grow at a CAGR of 29.7% during the forecast period. On the other hand, the Europe liquid biopsy market is projected to hold second leading stance by garnering a revenue of USD 1228.8 Million in 2021. The growth of the market in the region can be attributed to the rising healthcare expenditure in the major countries of Europe, such as Germany, UK, Spain, and Russia.

Furthermore, in the North American region, the United States is projected to generate significant growth opportunities for market growth by attaining a revenue of 1284.3 USD Million in 2021, while Canada is projected to reap 154.4 USD Million in revenue during the same year. The North American market presently captures the larger share due to the region's robust healthcare infrastructure. Additionally, the growing prevalence of cancer in the region is also expected to generate massive demand for liquid biopsy over the forecast period. Moreover, the increasing initiatives by the U.S. government to upgrade the facilities in cancer care is also expected to favor the market's growth in the coming years. Furthermore, improved research infrastructure and increasing investments in R&D in the healthcare industry alongside the initiatives taken by the U.S. government are some of the other factors expected to contribute to the growth of the market. Over the years, government spending on healthcare resources has significantly increased the regulatory landscape, which is also a prominent factor driving the market's growth.

Base Year	2024
Forecast Year	2025-2037
CAGR	12.3%
Base Year Market Size (2024)	USD 6.69 billion
Forecast Year Market Size (2037)	USD 30.22 billion
Regional Scope	North America (U.S., and Canada) Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific) Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Latin America (Mexico, Argentina, Brazil, Rest of Latin America) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Liquid Biopsy Market Trends

Liquid Biopsy Market Trends

Liquid Biopsy Market: Key Insights

Browse Key Market Insights with Data Illustration:

Frequently Asked Questions (FAQ)

Subscribe to Our Newsletters

Liquid Biopsy Market Trends

Liquid Biopsy Market Trends

Liquid Biopsy Market: Key Insights

Browse Key Market Insights with Data Illustration:

Frequently Asked Questions (FAQ)

How much is the liquid biopsy market worth?

Why is the demand for liquid biopsy growing?

Which region dominated the majority of liquid biopsy industry share?

Who are the top liquid biopsy companies?